COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Blood Advances Année : 2022

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

1 University Hospital of Cologne [Cologne]
2 University of Cologne
3 Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan]
4 UNIMI - Università degli Studi di Milano = University of Milan
5 IRE - IFO - Istituto Nazionale Tumori Regina Elena [Roma]
6 VHIO - Vall d'Hebron Institute of Oncology [Barcelone]
7 UAB - Universitat Autònoma de Barcelona
8 AP-HP - Hopital Saint-Louis [AP-HP]
9 CHU Saint-Antoine [AP-HP]
10 CRSA - Centre de Recherche Saint-Antoine
11 IGMM - Institut de Génétique Moléculaire de Montpellier
12 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
13 IRCCS Ospedale San Raffaele [Milan, Italy]
14 University Hospital Brno
15 University Hospital Centre Zagreb
16 University of Zagreb
17 Karolinska University Hospital [Stockholm]
18 FJD - Fundacion Jimenez Diaz [Madrid]
19 Comenius University in Bratislava
20 Hospital Universitario Virgen del Rocío [Sevilla]
21 Hospital Universitario La Paz
22 Hospital Universitario de Salamanca
23 Clinic Barcelona Hospital Universitari
24 University Hospital Basel [Basel]
25 Unibas - Université de Bâle = University of Basel
26 KCH - King's College Hospital
27 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
28 UC San Diego - University of California [San Diego]
29 Medical University of Graz
30 North-Western State Medical University [St Petersburg, Russia]
31 Uninsubria - Universitá degli Studi dell’Insubria = University of Insubria [Varese]
32 DZIF - German Centre for Infection Research
33 Fondazione Policlinico Universitario Agostino Gemelli IRCCS
34 Unicatt - Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma]
Alessandro Busca
Roberta Di Blasi
Barbora Weinbergerová
Alberto López-García
Ľuboš Drgoňa
Iker Falces-Romero
Austin Kulasekararaj
Antonio Pagliuca

Résumé

Key Points The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Fichier principal
Vignette du fichier
advancesadv2021005616.pdf (868.29 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03645421 , version 1 (19-04-2022)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, et al.. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. Blood Advances, 2022, 6 (7), pp.2427-2433. ⟨10.1182/bloodadvances.2021005616⟩. ⟨hal-03645421⟩
40 Consultations
39 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More